What Is the Difference Between HNPP and CMT Disease?

It is very common for people with Hereditary Neuropathy with liability to Pressure Palsies (HNPP) to be told their condition is in the Charcot-Marie-Tooth (CMT) “family.” The main difference between the two lies in their genetic causes and how their symptoms develop. While CMT is a broad umbrella term for many genetic neuropathies that generally cause a slow, progressive decline in nerve function ^[1], HNPP usually causes episodic nerve palsies triggered by physical pressure, stretch, or repetitive activity ^[2][3].

⚠️ When to Seek Emergency Care
Because HNPP causes sudden weakness or numbness, it is crucial to know the difference between a standard pressure palsy and a medical emergency.
Call 911 or go to the emergency room immediately if you experience:

• Sudden facial drooping or trouble speaking
• Sudden, unexplained weakness on one entire side of your body
• Difficulty breathing or swallowing
• New loss of bowel or bladder control
• Rapidly progressive weakness

For a new or persistent episode of your typical focal weakness or numbness, contact your neurology clinic for guidance.

The PMP22 Gene Connection (CMT1A vs. HNPP)

To understand the connection, it is helpful to look specifically at CMT1A, the most common type of CMT. HNPP and CMT1A are often considered opposite sides of the same genetic coin. Both conditions most commonly involve a gene called PMP22, which provides instructions for making a protein that helps form myelin ^[4]. Myelin is the protective coating around your peripheral nerves, similar to the insulation on an electrical wire ^[5].

• HNPP (Gene Deletion): Most people with HNPP are missing one copy of the PMP22 gene (a deletion). This results in decreased production of the PMP22 protein, leading to fragile myelin that is easily damaged by physical compression ^[5][4].
• CMT1A (Gene Duplication): People with CMT1A have an extra copy of the PMP22 gene (a duplication). This results in an overproduction of the PMP22 protein, which also disrupts the myelin structure, but in a different way ^[5][6].

Because both conditions involve an abnormal amount of the same protein, they are often grouped together medically as PMP22 dosage disorders ^[5]. Both are usually inherited in an autosomal dominant pattern, meaning a child has a 50% chance of inheriting the gene change from an affected parent ^[5][1]. However, it is important to note that CMT is a very broad group, and other types of CMT (as well as rare cases of HNPP) are caused by entirely different genetic variants ^[1].

Episodic vs. Progressive Symptoms

Because the underlying structural changes to the nerves are different, the day-to-day experience of HNPP and CMT1A typically differs, though neither condition has absolute rules:

• HNPP is usually episodic: Symptoms like numbness, tingling, and muscle weakness (palsies) typically occur suddenly after a nerve is compressed, stretched, or subjected to repetitive movement ^[3][7]. While episodes can happen without a clearly remembered trigger, and some people develop a mild background generalized neuropathy, the core feature of HNPP is these sudden focal attacks ^[8]. Symptoms usually improve over days to months, though incomplete recovery and persistent lingering deficits can happen over time ^[9].
• CMT1A is typically progressive: In contrast to the sudden episodes of HNPP, CMT1A is generally characterized by a slow, gradual worsening of muscle weakness and sensory loss ^[10], often starting in the feet and lower legs. The severity and rate of progression vary heavily from person to person ^[11][12]. While CMT1A symptoms generally do not fluctuate based on immediate physical pressure in the way HNPP symptoms do, people with CMT can still develop common pressure neuropathies.

Comparison: HNPP vs. CMT1A

Shared Care and Practical Management

Even though HNPP and CMT1A behave differently, they are both inherited peripheral neuropathies rooted in the same gene region. As a result, both conditions may be evaluated and managed by the same specialists in multidisciplinary inherited neuropathy or neuromuscular clinics ^[13][14].

To support and characterize your diagnosis, specialists use electrodiagnostic testing ^[15][1]. This usually includes Nerve Conduction Studies (NCS) to measure electrical signals along your nerves, and sometimes needle Electromyography (EMG) to assess muscle activity. While these tests help establish your baseline, repeated testing at every visit is not automatically required and depends on the specific clinical questions your doctor has.

What This Means in Daily Life:
Your care team will tailor management to your specific diagnosis. For CMT, care often involves individualized supportive multidisciplinary care, such as managing progressive weakness with physical therapy and orthotics. For HNPP, treatment focuses heavily on lifestyle modifications to prevent pressure-related episodes ^[13], such as:

• Ergonomics: Avoiding prolonged leaning on elbows, crossing legs, kneeling, or squatting ^[7]. Working with an occupational therapist (OT) or physical therapist (PT) can help you identify and modify triggers in your daily routine.
• Padding: Using padded elbow rests and avoiding tight clothing, braces, or casts.
• Medical and Surgical Precautions: It is absolutely vital to inform surgeons, anesthesiologists, and dentists about your HNPP. Prolonged immobility or specific positioning during surgery, childbirth, or recovery can trigger severe nerve palsies if extra positional care is not used ^[16][17].

Living with unpredictable episodes can be incredibly frustrating. While taking precautions reduces your risk of an episode, it cannot prevent every attack—so if an episode occurs, remember that it is a symptom of the condition, not a personal failure.

Glossary

• Myelin: The protective, insulating layer around peripheral nerves that helps electrical signals travel quickly.
• Nerve Palsy: A temporary or permanent loss of function (weakness or paralysis) and feeling in a nerve.
• Peripheral Nerves: The nerves outside of your brain and spinal cord that control your muscles and relay sensory information.
• PMP22: A gene that provides instructions for making a protein critical to the structure of myelin.